摘要
By a survey of metagenome-wide association studies (MWAS), we found a robust depletion of Bacteroides cellulosilyticus, Faecalibacterium prausnitzii, and Roseburia intestinalis in individuals with atherosclerotic cardiovascular disease (ACVD). From an established collection of bacteria isolated from healthy Chinese individuals, we selected B. cellulosilyticus, R. intestinalis, and Faecalibacterium longum, a bacterium related to F. prausnitzii, and tested the effects of these bacteria in an Apoe(/-) atherosclerosis mouse model. We show that administration of these three bacterial species to Apoe(-/-) mice robustly improves cardiac function, reduces plasma lipid levels, and attenuates the formation of atherosclerotic plaques. Comprehensive analysis of gut microbiota, plasma metabolome, and liver transcriptome revealed that the beneficial effects are associated with a modulation of the gut microbiota linked to a 7 alpha-dehydroxylation-lithocholic acid (LCA)-farnesoid X receptor (FXR) pathway. Our study provides insights into transcriptional and metabolic impact whereby specific bacteria may hold promises for prevention/treatment of ACVD.
学科与关键词
- Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid MetabolismGu, Yuyan; Zhang, Yaxin; Li, Mei; Huang, Zhiyong; Jiang, Jing; Chen, Yihao; Chen, Junqi; Jia, Yuhua; Zhang, Lihua*; Zhou, Fenghua*Frontiers in Pharmacology, 2021, 12: 621339.被引 37
- Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular DiseaseXue, Hongliang; Chen, Xu; Yu, Chao; Deng, Yuqing; Zhang, Yuan; Chen, Shen; Chen, Xuechen; Chen, Ke; Yang, Yan*; Ling, Wenhua*Circulation Research, 2022, 131(5): 404-420.被引 44
- Bacteroides fragilis Supplementation Deteriorated Metabolic Dysfunction, Inflammation, and Aorta Atherosclerosis by Inducing Gut Microbiota Dysbiosis in Animal ModelShi, Guoxiang; Lin, Yubi; Wu, Yuanyuan; Zhou, Jing; Cao, Lixiang; Chen, Jiyan; Li, Yong*; Tan, Ning*; Zhong, Shilong*OncoImmunology, 2022, 14(11): 2199.被引 10
